Antidiabetic drug causes double the weight loss of competitor in Type 2 diabetes patients eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
“Dr. Pollack is an astute and thoughtful higher education leader whose breadth of knowledge and depth of expertise position him well to build on the many strengths of our pharmacy school and cultivate pharmaceutical research scientists and clinicians who are committed to tackling society’s most pressing health care challenges. ”
President Satish K. Tripathi
Gary M. Pollack, professor and dean of the College of Pharmacy and Pharmaceutical Sciences at the University of Toledo, has been appointed dean of the School of Pharmacy and Pharmaceutical Sciences.
The announcement was made today by Provost A. Scott Weber, and Michael E. Cain, vice president for health sciences and dean of the Jacobs School of Medicine and Biomedical Sciences at UB. Pollack will join UB in August.
University at Buffalo
Teams will seek to develop treatment options that could benefit patients with multiple sclerosis, hemophilia and more
BUFFALO, N.Y. Two University at Buffalo drug development and discovery projects have received investments from the Empire Discovery Institute.
One project focuses on an immunotherapy platform developed by UB pharmacy researcher Sathy Balu-Iyer and his team that could benefit patients who are receiving gene therapy for a variety of diseases. The other will seek to design a therapy for multiple sclerosis (MS) that leverages a novel drug target discovered by a team led by UB medical researcher M. Laura Feltri.
UB programs continue to rise in U S News Best Grad School rankings buffalo.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from buffalo.edu Daily Mail and Mail on Sunday newspapers.
Study: 94% of older adults prescribed fall-risk-increasing drugs
Nearly every older adult was prescribed a prescription drug that increased their risk of falling in 2017, according to new University at Buffalo research.
The study found that the percentage of adults 65 and older who were prescribed a fall- risk-increasing drug climbed to 94% in 2017, a significant leap from 57% in 1999. The research also revealed that the rate of death caused by falls in older adults more than doubled during the same time period.
Even minor falls may be dangerous for older adults. Falls that are not fatal can still result in injuries - such as hip fractures and head traumas - that may drastically lower remaining quality of life. Each year, nearly $50 billion is spent on medical costs related to fall injuries among older adults, according to the Centers for Disease Control and Prevention.